Nocera Restates FY2024 and FY2025 Financials, Citing Material Weaknesses
NCRA sits 67% above its 52-week low of $1.3.
Summary
Nocera announced a restatement of its FY2024 and FY2025 financial statements due to errors, including a $1.35M goodwill reduction and $2.6M reduction in 2025 net sales, citing material weaknesses in internal controls.
Key Events · Legal and Risk Events · NCRA
-
Financial Statements Restated
Nocera concluded that its FY2024 and FY2025 financial statements should no longer be relied upon due to errors identified in a comprehensive reassessment.
-
Goodwill Reduced by $1.35M
Goodwill for fiscal 2024 was reduced by $1,351,703, from $2,077,728 to $726,025, reflecting a reassessment of recoverability.
-
2025 Net Sales Reduced by $2.6M
Previously reported net sales for fiscal 2025 were reduced by $2,597,349, offset by corresponding reductions in cost of sales and reclassifications to discontinued operations.
-
Accumulated Losses Increased by $2.1M
Total stockholders' equity as of December 31, 2024 was reduced by $2,096,572 due to the restatement adjustments.
Analysis · NCRA · Industrial Applications And Services
Nocera disclosed that its previously issued financial statements for fiscal years 2024 and 2025 should no longer be relied upon due to errors requiring restatement. The restatement includes a $1.35 million goodwill reduction, $2.6 million reduction in 2025 net sales, and a $2.1 million increase in accumulated losses. The company attributes the errors to material weaknesses in internal controls that it had previously disclosed. This is a significant governance and accounting failure that undermines confidence in reported financials.
At the time of this filing, NCRA was trading at $2.17 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.6M. The 52-week trading range was $1.30 to $72.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.